Evidence map›Paper›PMID 35011360›Full record

ArticleMolecules (Basel, Switzerland)2021

A GdW

Lixia Chen, Yang Zhang, Xinming Zhang, Ruijuan Lv, Rongtian Sheng, Ruimeng Sun, Ting Du, Yuhan Li, Yanfei Qi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Lixia ChenSchool of Public Health, Jilin University, Changchun 130021, China.
Yang ZhangSchool of Public Health, Jilin University, Changchun 130021, China.
Xinming ZhangSchool of Public Health, Jilin University, Changchun 130021, China.
Ruijuan LvSchool of Public Health, Jilin University, Changchun 130021, China.
Rongtian ShengSchool of Public Health, Jilin University, Changchun 130021, China.
Ruimeng SunSchool of Public Health, Jilin University, Changchun 130021, China.
Ting DuSchool of Public Health, Jilin University, Changchun 130021, China.
Yuhan LiSchool of Public Health, Jilin University, Changchun 130021, China.
Yanfei QiSchool of Public Health, Jilin University, Changchun 130021, China.ORCID 0000-0002-3093-6964
Jilin University · CN

Funding

Nation Natural Science Foundation of China NSFC 82073602Nation Natural Science Foundation of Jilin Province 20200201081JC
6 · The paper itself

Abstract

Anticancer treatment is largely affected by the hypoxic tumor microenvironment (TME), which causes the resistance of the tumor to radiotherapy. Combining radiosensitizer compounds and O

Indexed as

AnionsBiocompatible MaterialsCatalaseCell Line, TumorGadoliniumHT29 CellsHumansHydrogen PeroxideIndolesNanocompositesOxygenPolyelectrolytesPolymersPolyoxometalatesRadiation-Sensitizing AgentsReactive Oxygen SpeciesAnionsBiocompatible MaterialsCatalaseGadoliniumHydrogen PeroxideIndolesOxygenpolydopaminePolyelectrolytesPolymersPolyoxometalatesRadiation-Sensitizing AgentsReactive Oxygen SpeciesTungstencatalaseO2 self-supplementpolyoxometalatesradiosensitizerradiotherapy

Identifiers

PMID35011360
PMCPMC8746738
OpenAlexW4200514180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.